Apyx Medical (APYX) Capital Expenditures Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.76% |
| Dec 31, 2025 | -6.65% |
| Sep 30, 2025 | 125.00% |
| Jun 30, 2025 | 23.03% |
| Mar 31, 2025 | -9.38% |
| Dec 31, 2024 | 1.72% |
| Sep 30, 2024 | -22.80% |
| Jun 30, 2024 | -6.34% |
| Mar 31, 2024 | -21.44% |
| Dec 31, 2023 | -10.28% |
| Sep 30, 2023 | 27.34% |
| Jun 30, 2023 | -4.17% |
| Mar 31, 2023 | -4.57% |
| Dec 31, 2022 | -5.95% |
| Sep 30, 2022 | -7.66% |
| Jun 30, 2022 | 38.04% |
| Mar 31, 2022 | 31.48% |
| Dec 31, 2021 | 26.13% |
| Sep 30, 2021 | 3.81% |
| Jun 30, 2021 | 7.71% |
| Mar 31, 2021 | 55.67% |
| Dec 31, 2020 | 32.73% |
| Sep 30, 2020 | -42.40% |
| Jun 30, 2020 | -14.69% |
| Mar 31, 2020 | -18.74% |
| Dec 31, 2019 | -6.27% |
| Sep 30, 2019 | 29.20% |
| Jun 30, 2019 | 35.13% |
| Mar 31, 2019 | 9.30% |
| Dec 31, 2018 | -1.32% |
| Mar 31, 2018 | 1.19% |
| Dec 31, 2017 | -8.69% |
| Sep 30, 2017 | 11.57% |
| Jun 30, 2017 | 12.70% |
| Mar 31, 2017 | -21.81% |
| Dec 31, 2016 | 4.61% |
| Sep 30, 2016 | -6.56% |
| Jun 30, 2016 | -35.98% |
| Mar 31, 2016 | -22.48% |